TRUBRIDGE INC (TBRG) Stock Fundamental Analysis
NASDAQ:TBRG - US2053061030 - Common Stock
20.18 USD
+0.17 (+0.85%)
Taking everything into account, TBRG scores 4 out of 10 in our fundamental rating. TBRG was compared to 35 industry peers in the Health Care Technology industry. There are concerns on the financial health of TBRG while its profitability can be described as average. TBRG may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
In the past year TBRG was profitable.
TBRG had a positive operating cash flow in the past year.
In multiple years TBRG reported negative net income over the last 5 years.
TBRG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of -2.41%, TBRG is doing good in the industry, outperforming 77.14% of the companies in the same industry.
Looking at the Return On Equity, with a value of -5.43%, TBRG is in the better half of the industry, outperforming 77.14% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.32%, TBRG belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.41% | ||
| ROE | -5.43% | ||
| ROIC | 5.32% |
ROA(3y)-3.89%
ROA(5y)-0.55%
ROE(3y)-9.64%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TBRG's Operating Margin of 6.59% is fine compared to the rest of the industry. TBRG outperforms 77.14% of its industry peers.
TBRG's Operating Margin has declined in the last couple of years.
TBRG has a Gross Margin of 52.76%. This is comparable to the rest of the industry: TBRG outperforms 45.71% of its industry peers.
In the last couple of years the Gross Margin of TBRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.59% | ||
| PM (TTM) | N/A | ||
| GM | 52.76% |
OM growth 3Y-40.35%
OM growth 5Y-26.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.64%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TBRG is destroying value.
The number of shares outstanding for TBRG has been increased compared to 1 year ago.
The number of shares outstanding for TBRG has been increased compared to 5 years ago.
The debt/assets ratio for TBRG has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.00 indicates that TBRG is not a great score, but indicates only limited risk for bankruptcy at the moment.
TBRG has a better Altman-Z score (2.00) than 65.71% of its industry peers.
The Debt to FCF ratio of TBRG is 10.13, which is on the high side as it means it would take TBRG, 10.13 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 10.13, TBRG perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
A Debt/Equity ratio of 0.94 indicates that TBRG is somewhat dependend on debt financing.
TBRG has a worse Debt to Equity ratio (0.94) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.94 | ||
| Debt/FCF | 10.13 | ||
| Altman-Z | 2 |
ROIC/WACC0.5
WACC10.55%
2.3 Liquidity
TBRG has a Current Ratio of 1.80. This is a normal value and indicates that TBRG is financially healthy and should not expect problems in meeting its short term obligations.
TBRG has a Current ratio of 1.80. This is in the lower half of the industry: TBRG underperforms 62.86% of its industry peers.
A Quick Ratio of 1.79 indicates that TBRG should not have too much problems paying its short term obligations.
TBRG has a worse Quick ratio (1.79) than 62.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.79 |
3. Growth
3.1 Past
TBRG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.21%.
TBRG shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -40.46% yearly.
The Revenue for TBRG has decreased by -17.20% in the past year. This is quite bad
Measured over the past years, TBRG shows a small growth in Revenue. The Revenue has been growing by 4.53% on average per year.
EPS 1Y (TTM)-36.21%
EPS 3Y-58.61%
EPS 5Y-40.46%
EPS Q2Q%237.5%
Revenue 1Y (TTM)-17.2%
Revenue growth 3Y6.89%
Revenue growth 5Y4.53%
Sales Q2Q%1.18%
3.2 Future
Based on estimates for the next years, TBRG will show a very strong growth in Earnings Per Share. The EPS will grow by 132.46% on average per year.
Based on estimates for the next years, TBRG will show a small growth in Revenue. The Revenue will grow by 3.80% on average per year.
EPS Next Y966.97%
EPS Next 2Y247.16%
EPS Next 3Y132.46%
EPS Next 5YN/A
Revenue Next Year3.3%
Revenue Next 2Y3.82%
Revenue Next 3Y3.8%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 27.27, which means the current valuation is very expensive for TBRG.
Compared to the rest of the industry, the Price/Earnings ratio of TBRG indicates a rather cheap valuation: TBRG is cheaper than 82.86% of the companies listed in the same industry.
TBRG's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.08.
A Price/Forward Earnings ratio of 8.81 indicates a reasonable valuation of TBRG.
TBRG's Price/Forward Earnings ratio is rather cheap when compared to the industry. TBRG is cheaper than 97.14% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of TBRG to the average of the S&P500 Index (22.67), we can say TBRG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.27 | ||
| Fwd PE | 8.81 |
4.2 Price Multiples
97.14% of the companies in the same industry are more expensive than TBRG, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of TBRG indicates a rather cheap valuation: TBRG is cheaper than 88.57% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.48 | ||
| EV/EBITDA | 9.25 |
4.3 Compensation for Growth
TBRG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TBRG's earnings are expected to grow with 132.46% in the coming years.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y247.16%
EPS Next 3Y132.46%
5. Dividend
5.1 Amount
TBRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:TBRG (8/27/2025, 2:54:57 PM)
20.18
+0.17 (+0.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners67.96%
Inst Owner Change0%
Ins Owners3.17%
Ins Owner Change10.64%
Market Cap302.90M
Analysts78
Price Target25.25 (25.12%)
Short Float %6.34%
Short Ratio4.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.79%
Min EPS beat(2)20.66%
Max EPS beat(2)122.91%
EPS beat(4)2
Avg EPS beat(4)-29.99%
Min EPS beat(4)-176.25%
Max EPS beat(4)122.91%
EPS beat(8)5
Avg EPS beat(8)-12.21%
EPS beat(12)6
Avg EPS beat(12)-13.47%
EPS beat(16)8
Avg EPS beat(16)-8.87%
Revenue beat(2)0
Avg Revenue beat(2)-2.06%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-0.83%
Revenue beat(4)1
Avg Revenue beat(4)-0.86%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)1.51%
Revenue beat(8)2
Avg Revenue beat(8)-1.27%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)5
Avg Revenue beat(16)-0.61%
PT rev (1m)-15.38%
PT rev (3m)-15.38%
EPS NQ rev (1m)37.23%
EPS NQ rev (3m)1.62%
EPS NY rev (1m)48.32%
EPS NY rev (3m)44.81%
Revenue NQ rev (1m)-2.82%
Revenue NQ rev (3m)-4.48%
Revenue NY rev (1m)-1.69%
Revenue NY rev (3m)-1.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.27 | ||
| Fwd PE | 8.81 | ||
| P/S | 0.87 | ||
| P/FCF | 18.48 | ||
| P/OCF | 8.67 | ||
| P/B | 1.75 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.25 |
EPS(TTM)0.74
EY3.67%
EPS(NY)2.29
Fwd EY11.35%
FCF(TTM)1.09
FCFY5.41%
OCF(TTM)2.33
OCFY11.53%
SpS23.16
BVpS11.54
TBVpS-7.55
PEG (NY)0.03
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.41% | ||
| ROE | -5.43% | ||
| ROCE | 6.74% | ||
| ROIC | 5.32% | ||
| ROICexc | 5.52% | ||
| ROICexgc | 43.92% | ||
| OM | 6.59% | ||
| PM (TTM) | N/A | ||
| GM | 52.76% | ||
| FCFM | 4.72% |
ROA(3y)-3.89%
ROA(5y)-0.55%
ROE(3y)-9.64%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-34.77%
ROICexcg growth 5Y-16.72%
ROICexc growth 3Y-36.47%
ROICexc growth 5Y-24.96%
OM growth 3Y-40.35%
OM growth 5Y-26.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.64%
F-Score7
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.94 | ||
| Debt/FCF | 10.13 | ||
| Debt/EBITDA | 3.32 | ||
| Cap/Depr | 70.69% | ||
| Cap/Sales | 5.33% | ||
| Interest Coverage | 1.58 | ||
| Cash Conversion | 71.1% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.79 | ||
| Altman-Z | 2 |
F-Score7
WACC10.55%
ROIC/WACC0.5
Cap/Depr(3y)79.13%
Cap/Depr(5y)69.66%
Cap/Sales(3y)6.13%
Cap/Sales(5y)4.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.21%
EPS 3Y-58.61%
EPS 5Y-40.46%
EPS Q2Q%237.5%
EPS Next Y966.97%
EPS Next 2Y247.16%
EPS Next 3Y132.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.2%
Revenue growth 3Y6.89%
Revenue growth 5Y4.53%
Sales Q2Q%1.18%
Revenue Next Year3.3%
Revenue Next 2Y3.82%
Revenue Next 3Y3.8%
Revenue Next 5YN/A
EBIT growth 1Y256.08%
EBIT growth 3Y-36.24%
EBIT growth 5Y-23.05%
EBIT Next Year149.44%
EBIT Next 3Y43.12%
EBIT Next 5YN/A
FCF growth 1Y2208.59%
FCF growth 3Y-29.73%
FCF growth 5Y-20.85%
OCF growth 1Y48.79%
OCF growth 3Y-12.4%
OCF growth 5Y-5.94%